We suggest that a threshold of blood glucose lowering may be required to achieve renoprotection in diabetes, which may differ for individual parameters, as evidenced by some, but not all, features of kidney disease improving with SGLT2 inhibition in our study. Here, SLC5A2 is linked to diabetes mellitus.